Roopa Industries

Roopa Industries Acquisitions (Net)

The Acquisitions (Net) of Roopa Industries (530991.BO) as of Oct 31, 2026 is 30.32 M INR. In the previous year, Acquisitions (Net) was 11.13 M INR — a change of 172.35% (higher).

Acquisitions (Net)

30.32 MINR

YoY

172.35%

Last updated:

Acquisitions (Net) of Roopa Industries is 2025 30.32 M INR. Acquisitions (Net) of Roopa Industries was 2024 11.13 M INR. It decreases by 172.35% higher compared to the previous year.

The Roopa Industries Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2018
49.17 M INR
Jan 1, 2019
2.51 M INR
Jan 1, 2020
12.03 M INR
Jan 1, 2021
20.79 M INR
Jan 1, 2022
44.96 M INR
Jan 1, 2023
3.84 M INR
Jan 1, 2024
11.13 M INR
Jan 1, 2025
30.32 M INR
The Roopa Industries Acquisitions (Net) history
YEARAcquisitions (Net)YoY
30.32 MINR+172.35%
11.13 MINR+189.87%
3.84 MINR-91.46%
44.96 MINR+116.26%
20.79 MINR+72.81%
12.03 MINR+379.22%
2.51 MINR-94.89%
49.17 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Roopa Industries Stock analysis

What does Roopa Industries do? Roopa Industries Ltd. manufactures pharmaceutical products, focusing on bulk drugs and drug intermediates. The company produces N,N-dicyclohexylcarbodiimide (DCC), Triphenyl Phosphine (TPP), 5-Cyano Phthalide, Glucosamine, and Bromine And Its Derivatives. Triphenyl Phosphine is used by manufacturers of Cephalosporin antibiotics and Statins, while Bromine And Its Derivatives serve agrochemicals, dyes, medical and veterinary products, water purification, and pesticides. Glucosamine is a key nutraceutical product. The primary buyers include pharmaceutical manufacturers, agrochemical companies, and producers of medical and veterinary compounds. The company's revenue streams come from the sale of these specialized chemical products to industries requiring bulk drugs and intermediates. Triphenyl Phosphine supports antibiotic and statin production, making it essential for pharmaceutical firms. Bromine And Its Derivatives cater to diverse sectors like agriculture, water treatment, and disinfection, with significant demand from agrochemical and medical product manufacturers. Glucosamine, as a sheet anchor product, drives sales in the nutraceutical market. Roopa Industries targets the pharmaceutical, agrochemical, and medical sectors with its product portfolio. The firm's focus on bulk drugs and intermediates positions it as a supplier to manufacturers of antibiotics, statins, and nutraceuticals. Its products are integral to the production of Cephalosporin group antibiotics, Statins, and various agrochemical applications, ensuring consistent demand from established industrial buyers. Roopa Industries is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Roopa Industries stock

Acquisitions (Net) of Roopa Industries is 30.32 M INR in 2025.

Acquisitions (Net) of Roopa Industries changed from 11.13 M INR to 30.32 M INR, representing a 172.35% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Roopa Industries since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Roopa Industries historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Roopa Industries

All Key Metrics — Roopa Industries